BCL9 and hepatocellular carcinoma: In agreement with the in vitro studies, analysis of an in vivo HCC mouse model showed that the WT or mutant BCL9, especially BCL9D349V and BCL9S278N, substantially promoted tumor growth and pulmonary metastasis (Fig. 8d).